Japanese health authorities approves concurrent therapy of Fastic
Nateglinide is a fast-acting postprandial hypoglycemic agent for use in combination therapy. It was developed by the Ast...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
